PharmiWeb Today Story
New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen)
BURLINGTON, N.C., April 1, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human papillomavirus (HPV) self-collection solution that can help women and their physicians asses the risk of developing cervical cancer. Labcorp will also offer a vaginal swab self-collect option for sexually transmitted infection (STI) testing. Both solutions are available by physician order and can be completed privately in a healthcare setting or at any one of Labcorp's 2,200 Patient Service Centers (PSCs) nationwide.
"Many patients delay or avoid necessary health screenings due to discomfort, stigma or time challenges, which can lead to health complications and further spread infections," said Dr. Brian Caveney, Labcorp's chief medical and scientific officer. "Labcorp is now offering self-collection at our PSCs and healthcare settings such as physician offices to break down these barriers. With convenient access to essential tests and screenings, patients can take control of their health, on their own terms, when it's most convenient for them."
Expanding Access to Cervical Cancer Screening
Each year in the U.S. more than 13,000 women are diagnosed with cervical cancer an…

Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
Next Generation Cancer Vaccine Development Summit…
07-Sep-2021 - 09-Sep-2021 -
1st International Conference “WE! are the Clinical…
18-Sep-2021 - 18-Sep-2021 -
Reuters Events: Cell & Gene Therapy USA 2021
28-Sep-2021 - 29-Sep-2021 -
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
UK Clinical Research: A Professional Awareness Upd…
26-Jan-2022 - 27-Jan-2022 -
Genomics and Precision Medicine Expo
23-May-2023 - 24-May-2023
News

-
Global Cytogenetic Systems Market Poised for Remar…
03-Apr-2025 -
My Compounding Pharmacy Roselands, Based in Sydney…
02-Apr-2025 -
Boehringer Ingelheim reaches more patients in 2024…
02-Apr-2025 -
Tiziana Life Sciences Announces Johns Hopkins Univ…
02-Apr-2025 -
Mid Yorkshire Teaching NHS Trust reduces SSI rates…
02-Apr-2025 -
NICE publishes guidance in England & Wales recomme…
02-Apr-2025